Custom Antibody Market - Forecast to 2031

Home » Pharmaceuticals » Custom Antibody Market

Custom Antibody Market Analysis and Forecast to 2031: By Service (Antibody Development, Production, Labelling), Type (Monoclonal, Polyclonal, Recombinant), Source (Rabbit, Mice), Research Area (Oncology, Immunology), and Region

Report Code : GIS20780 Number of Pages: 159

Industry : Pharmaceuticals Publication Status : Upcoming

A custom antibody is an antibody that is produced to specifically target a particular protein. Antibodies are proteins that are produced by the immune system in response to foreign substances, such as bacteria or viruses. The immune system uses antibodies to identify and neutralize these foreign substances.

Custom antibodies are produced by injecting animals with a protein that is specific to the protein of interest. The animals produce antibodies against this protein, which are then isolated and purified. Custom antibodies can be used for a variety of purposes, including research, diagnosis, and treatment of disease.

Key Trends

There are several key trends in Custom Antibody technology that are worth noting. First, the technology is becoming more sophisticated and able to target specific proteins with greater accuracy. Additionally, the technology is becoming more affordable, making it more accessible to a wider range of researchers. Finally, the technology is becoming more user-friendly, making it easier to use for those who are not experts in the field.

Key Drivers

The key drivers of the Custom Antibody market are the increasing demand for research and development in the biotechnology and pharmaceutical industries, and the need for high-quality antibodies for a variety of applications. The market is also driven by the increasing availability of new technologies and the growing number of companies offering custom antibody services.

The demand for custom antibodies is driven by the increasing number of research and development activities in the biotechnology and pharmaceutical industries.

The need for high-quality antibodies for a variety of applications is another key driver of the market. The increasing availability of new technologies, such as monoclonal antibody technology, is also driving the market.

The growing number of companies offering custom antibody services is another factor driving the market.

Restraints & Challenges

The key restraints and challenges in the Custom Antibody market are the high cost of development, the long development timelines, and the regulatory hurdles.

The high cost of development is due to the need for specialized equipment and expertise, and the long development timelines are due to the need to generate and test large numbers of antibodies.

The regulatory hurdles are due to the need to obtain approval from the US Food and Drug Administration (FDA) and other regulatory agencies.

Market Segments

The Custom Antibody Market is segmented by service, type, source, research area, and region. By service, the market is divided into antibody development, production and labelling. Based on type it is segmented into monoclonal, polyclonal and recombinant. On the basis of source, it is bifurcated into rabbit and mice. Based on research area, it is bifurcated into oncology and immunology. Region-wise, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World.

Key Players

The Custom Antibody Market includes players such as Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck Group, Cell Signaling Technology, Inc., GenScript, BioLegend, Rockland Immunochemicals, Abcam plc, Agilent Technologies Inc., and Innovagen AB.

Why GIS?

Download Nulled WordPress Themes

free download udemy course

download huawei firmware

Download Premium WordPress Themes Free

online free course

Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. Custom Antibody Market Outlook
3.1. Custom Antibody Market Segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Custom Antibody Market

Chapter 4. Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Custom Antibody Market
4.3. Economic Impact Analysis

Chapter 5. Custom Antibody Market by Service
5.1. Market Overview
5.2. Antibody Development
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Antibody Production
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million) \
5.4. Antibody Labeling
5.4.1. Market Size and Forecast, 2021-2031 ($Million)
5.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 6. Custom Antibody Market by Type
6.1. Market Overview
6.2. Monoclonal Antibodies
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Polyclonal Antibodies
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.4. Recombinant Antibodies
6.4.1. Market Size and Forecast, 2021-2031 ($Million)
6.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 7. Custom Antibody Market by Source
7.1. Market Overview
7.2. Mice
7.2.1. Market Size and Forecast, 2021-2031 ($Million)
7.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.3. Rabbits
7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 8. Custom Antibody Market by Research Area
8.1. Market Overview
8.2. Oncology
8.2.1. Market Size and Forecast, 2021-2031 ($Million)
8.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
8.3. Immunology
8.3.1. Market Size and Forecast, 2021-2031 ($Million)
8.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
8.4. Industrial
8.4.1. Market Size and Forecast, 2021-2031 ($Million)
8.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
8.5. Others
8.5.1. Market Size and Forecast, 2021-2031 ($Million)
8.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 9. Custom Antibody Market, by Region
9.1. Overview
9.2. North America
9.2.1. Key Market Trends and Opportunities
9.2.2. North America Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.2.3. North America Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.2.4. North America Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.2.5. North America Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.2.6. North America Custom Antibody Market Size and Forecast by Country, 2021-2031, ($Million)
9.2.7. The U.S.
9.2.7.1. The U.S. Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.2.7.2. The U.S. Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.2.7.3. The U.S. Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.2.7.4. The U.S. Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.2.8. Canada
9.2.8.1. Canada Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.2.8.2. Canada Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.2.8.3. Canada Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.2.8.4. Canada Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.2.9. Mexico
9.2.9.1. Mexico Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.2.9.2. Mexico Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.2.9.3. Mexico Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.2.9.4. Mexico Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.3. Europe
9.3.1. Key Market Trends and Opportunities
9.3.2. Europe Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.3.3. Europe Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.3.4. Europe Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.3.5. Europe Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.3.6. Europe Custom Antibody Market Size and Forecast by Country, 2021-2031, ($Million)
9.3.7. Germany
9.3.7.1. Germany Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.3.7.2. Germany Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.3.7.3. Germany Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.3.7.4. Germany Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.3.8. France
9.3.8.1. France Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.3.8.2. France Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.3.8.3. France Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.3.8.4. France Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.3.9. U.K.
9.3.9.1. U.K. Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.3.9.2. U.K. Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.3.9.3. U.K. Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.3.9.4. U.K. Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.3.10. Spain
9.3.10.1. Spain Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.3.10.2. Spain Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.3.10.3. Spain Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.3.10.4. Spain Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.3.11. Italy
9.3.11.1. Italy Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.3.11.2. Italy Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.3.11.3. Italy Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.3.11.4. Italy Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.3.12. Rest of Europe
9.3.12.1. Rest of Europe Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.3.12.2. Rest of Europe Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.3.12.3. Rest of Europe Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.3.12.4. Rest of Europe Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.4. Asia-Pacific
9.4.1. Key Market Trends and Opportunities
9.4.2. Asia-Pacific Custom Antibody Market Size and Forecast by Country, 2021-2031, ($Million)
9.4.3. Asia-Pacific Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.4.4. Asia-Pacific Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.4.5. Asia-Pacific Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.4.6. Asia-Pacific Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.4.7. China
9.4.7.1. China Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.4.7.2. China Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.4.7.3. China Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.4.7.4. China Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.4.8. India
9.4.8.1. India Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.4.8.2. India Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.4.8.3. India Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.4.8.4. India Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.4.9. Japan
9.4.9.1. Japan Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.4.9.2. Japan Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.4.9.3. Japan Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.4.9.4. Japan Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.4.10. South Korea
9.4.10.1. South Korea Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.4.10.2. South Korea Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.4.10.3. South Korea Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.4.10.4. South Korea Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.4.11. Rest of APAC
9.4.11.1. Rest of APAC Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.4.11.2. Rest of APAC Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.4.11.3. Rest of APAC Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.4.11.4. Rest of APAC Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.5. Rest of the World
9.5.1. Key Market Trends and Opportunities
9.5.2. Rest of the World Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.5.3. Rest of the World Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.5.4. Rest of the World Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.5.5. Rest of the World Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.5.6. Rest of the World Custom Antibody Market Size and Forecast by Country, 2021-2031, ($Million)
9.5.7. Latin America
9.5.7.1. Latin America Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.5.7.2. Latin America Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.5.7.3. Latin America Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.5.7.4. Latin America Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.5.8. Middle East
9.5.8.1. Middle East Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.5.8.2. Middle East Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.5.8.3. Middle East Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.5.8.4. Middle East Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)
9.5.9. Africa
9.5.9.1. Africa Custom Antibody Market Size and Forecast by Service, 2021-2031, ($Million)
9.5.9.2. Africa Custom Antibody Market Size and Forecast by Type, 2021-2031, ($Million)
9.5.9.3. Africa Custom Antibody Market Size and Forecast by Source, 2021-2031, ($Million)
9.5.9.4. Africa Custom Antibody Market Size and Forecast by Research Area, 2021-2031, ($Million)

Chapter 10. Competitive Landscape
10.1. Market Overview
10.2. Market Share Analysis/Key Player Positioning
10.3. Developmental Strategy Benchmarking
10.3.1. New Product Development
10.3.2. Product Launches
10.3.3. Business Expansions
10.3.4. Partnerships, Joint Ventures, and Collaborations
10.3.5. Mergers and Acquisitions

Chapter 11. Company Profiles
11.1. Thermo Fisher Scientific, Inc.
11.1.1. Company Snapshot
11.1.2. Financial Performance
11.1.3. Product Offerings
11.1.4. Key Strategic Initiatives
11.1.5. SWOT Analysis
11.2. Bio-Rad Laboratories, Inc.
11.2.1. Company Snapshot
11.2.2. Financial Performance
11.2.3. Product offerings
11.2.4. Key Strategic Initiatives
11.2.5. SWOT Analysis
11.3. Merck Group
11.3.1. Company Snapshot
11.3.2. Financial Performance
11.3.3. Product offerings
11.3.4. Key Strategic Initiatives
11.3.5. SWOT Analysis
11.4. Cell Signaling Technology, Inc.
11.4.1. Company Snapshot
11.4.2. Financial Performance
11.4.3. Product offerings
11.4.4. Key Strategic Initiatives
11.4.5. SWOT Analysis
11.5. GenScript
11.5.1. Company Snapshot
11.5.2. Financial Performance
11.5.3. Product offerings
11.5.4. Key Strategic Initiatives
11.5.5. SWOT Analysis
11.6. BioLegend
11.6.1. Company Snapshot
11.6.2. Financial Performance
11.6.3. Product offerings
11.6.4. Key Strategic Initiatives
11.6.5. SWOT Analysis
11.7. Rockland Immunochemicals
11.7.1. Company Snapshot
11.7.2. Financial Performance
11.7.3. Product offerings
11.7.4. Key Strategic Initiatives
11.7.5. SWOT Analysis
11.8. Abcam plc
11.8.1. Company Snapshot
11.8.2. Financial Performance
11.8.3. Product offerings
11.8.4. Key Strategic Initiatives
11.8.5. SWOT Analysis
11.9. Agilent Technologies Inc
11.9.1. Company Snapshot
11.9.2. Financial Performance
11.9.3. Product offerings
11.9.4. Key Strategic Initiatives
11.9.5. SWOT Analysis
11.10. Innovagen AB
11.10.1. Company Snapshot
11.10.2. Financial Performance
11.10.3. Product offerings
11.10.4. Key Strategic Initiatives
11.10.5. SWOT Analysis